nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosfomycin—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00169	0.00169	CcSEcCtD
Fosfomycin—Back pain—Orlistat—type 2 diabetes mellitus	0.00168	0.00168	CcSEcCtD
Fosfomycin—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.00167	0.00167	CcSEcCtD
Fosfomycin—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.00167	0.00167	CcSEcCtD
Fosfomycin—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.00166	0.00166	CcSEcCtD
Fosfomycin—Anorexia—Glyburide—type 2 diabetes mellitus	0.00166	0.00166	CcSEcCtD
Fosfomycin—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.00165	0.00165	CcSEcCtD
Fosfomycin—Rhinitis—Losartan—type 2 diabetes mellitus	0.00164	0.00164	CcSEcCtD
Fosfomycin—Myalgia—Gliclazide—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Fosfomycin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Fosfomycin—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Fosfomycin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00163	0.00163	CcSEcCtD
Fosfomycin—Nausea—Repaglinide—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Fosfomycin—Asthenia—Glipizide—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Fosfomycin—Pharyngitis—Losartan—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Fosfomycin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00162	0.00162	CcSEcCtD
Fosfomycin—Angioedema—Valsartan—type 2 diabetes mellitus	0.00161	0.00161	CcSEcCtD
Fosfomycin—Pruritus—Glipizide—type 2 diabetes mellitus	0.0016	0.0016	CcSEcCtD
Fosfomycin—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00159	0.00159	CcSEcCtD
Fosfomycin—Angioedema—Orlistat—type 2 diabetes mellitus	0.00159	0.00159	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.00158	0.00158	CcSEcCtD
Fosfomycin—Flatulence—Metformin—type 2 diabetes mellitus	0.00158	0.00158	CcSEcCtD
Fosfomycin—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.00156	0.00156	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00155	0.00155	CcSEcCtD
Fosfomycin—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00155	0.00155	CcSEcCtD
Fosfomycin—Infection—Gliclazide—type 2 diabetes mellitus	0.00155	0.00155	CcSEcCtD
Fosfomycin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00155	0.00155	CcSEcCtD
Fosfomycin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Fosfomycin—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.00153	0.00153	CcSEcCtD
Fosfomycin—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.00152	0.00152	CcSEcCtD
Fosfomycin—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Fosfomycin—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Fosfomycin—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00151	0.00151	CcSEcCtD
Fosfomycin—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Fosfomycin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Fosfomycin—Myalgia—Valsartan—type 2 diabetes mellitus	0.0015	0.0015	CcSEcCtD
Fosfomycin—Dizziness—Glipizide—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Fosfomycin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Fosfomycin—Flatulence—Irbesartan—type 2 diabetes mellitus	0.00149	0.00149	CcSEcCtD
Fosfomycin—Tension—Irbesartan—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Fosfomycin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Fosfomycin—Myalgia—Orlistat—type 2 diabetes mellitus	0.00148	0.00148	CcSEcCtD
Fosfomycin—Nervousness—Irbesartan—type 2 diabetes mellitus	0.00147	0.00147	CcSEcCtD
Fosfomycin—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00146	0.00146	CcSEcCtD
Fosfomycin—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00145	0.00145	CcSEcCtD
Fosfomycin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Fosfomycin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Fosfomycin—Vomiting—Glipizide—type 2 diabetes mellitus	0.00144	0.00144	CcSEcCtD
Fosfomycin—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Fosfomycin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00143	0.00143	CcSEcCtD
Fosfomycin—Infection—Valsartan—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Fosfomycin—Rash—Glipizide—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Fosfomycin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Fosfomycin—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00142	0.00142	CcSEcCtD
Fosfomycin—Headache—Glipizide—type 2 diabetes mellitus	0.00141	0.00141	CcSEcCtD
Fosfomycin—Insomnia—Gliclazide—type 2 diabetes mellitus	0.00141	0.00141	CcSEcCtD
Fosfomycin—Infection—Orlistat—type 2 diabetes mellitus	0.00141	0.00141	CcSEcCtD
Fosfomycin—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Fosfomycin—Flatulence—Losartan—type 2 diabetes mellitus	0.0014	0.0014	CcSEcCtD
Fosfomycin—Tension—Losartan—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Fosfomycin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Fosfomycin—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Fosfomycin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Fosfomycin—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00139	0.00139	CcSEcCtD
Fosfomycin—Nervousness—Losartan—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Fosfomycin—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Fosfomycin—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00138	0.00138	CcSEcCtD
Fosfomycin—Back pain—Losartan—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Fosfomycin—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Fosfomycin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Fosfomycin—Anorexia—Valsartan—type 2 diabetes mellitus	0.00137	0.00137	CcSEcCtD
Fosfomycin—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Fosfomycin—Myalgia—Metformin—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Fosfomycin—Headache—Pioglitazone—type 2 diabetes mellitus	0.00136	0.00136	CcSEcCtD
Fosfomycin—Nausea—Glipizide—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Fosfomycin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Fosfomycin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00134	0.00134	CcSEcCtD
Fosfomycin—Pain—Gliclazide—type 2 diabetes mellitus	0.00133	0.00133	CcSEcCtD
Fosfomycin—Constipation—Gliclazide—type 2 diabetes mellitus	0.00133	0.00133	CcSEcCtD
Fosfomycin—Rash—Glimepiride—type 2 diabetes mellitus	0.00133	0.00133	CcSEcCtD
Fosfomycin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00133	0.00133	CcSEcCtD
Fosfomycin—Rash—Sitagliptin—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Fosfomycin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Fosfomycin—Headache—Glimepiride—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Fosfomycin—Headache—Sitagliptin—type 2 diabetes mellitus	0.00132	0.00132	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00131	0.00131	CcSEcCtD
Fosfomycin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Fosfomycin—Angioedema—Losartan—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Fosfomycin—Infection—Metformin—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Fosfomycin—Insomnia—Valsartan—type 2 diabetes mellitus	0.0013	0.0013	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Fosfomycin—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Fosfomycin—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00129	0.00129	CcSEcCtD
Fosfomycin—Insomnia—Orlistat—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.00128	0.00128	CcSEcCtD
Fosfomycin—Somnolence—Valsartan—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Fosfomycin—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Fosfomycin—Skin disorder—Metformin—type 2 diabetes mellitus	0.00127	0.00127	CcSEcCtD
Fosfomycin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Fosfomycin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Fosfomycin—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00126	0.00126	CcSEcCtD
Fosfomycin—Nausea—Glimepiride—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Fosfomycin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Fosfomycin—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Fosfomycin—Asthenia—Glyburide—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Fosfomycin—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.00125	0.00125	CcSEcCtD
Fosfomycin—Anorexia—Metformin—type 2 diabetes mellitus	0.00124	0.00124	CcSEcCtD
Fosfomycin—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Fosfomycin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Fosfomycin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Fosfomycin—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Fosfomycin—Pruritus—Glyburide—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Fosfomycin—Constipation—Valsartan—type 2 diabetes mellitus	0.00123	0.00123	CcSEcCtD
Fosfomycin—Infection—Irbesartan—type 2 diabetes mellitus	0.00122	0.00122	CcSEcCtD
Fosfomycin—Pain—Orlistat—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Fosfomycin—Myalgia—Losartan—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Fosfomycin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00121	0.00121	CcSEcCtD
Fosfomycin—Rash—Bromocriptine—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Fosfomycin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Fosfomycin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Fosfomycin—Tension—Ramipril—type 2 diabetes mellitus	0.0012	0.0012	CcSEcCtD
Fosfomycin—Headache—Bromocriptine—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Fosfomycin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.00119	0.00119	CcSEcCtD
Fosfomycin—Nervousness—Ramipril—type 2 diabetes mellitus	0.00118	0.00118	CcSEcCtD
Fosfomycin—Dry mouth—Losartan—type 2 diabetes mellitus	0.00118	0.00118	CcSEcCtD
Fosfomycin—Anorexia—Irbesartan—type 2 diabetes mellitus	0.00117	0.00117	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.00117	0.00117	CcSEcCtD
Fosfomycin—Paraesthesia—Metformin—type 2 diabetes mellitus	0.00117	0.00117	CcSEcCtD
Fosfomycin—Somnolence—Metformin—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Fosfomycin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.00116	0.00116	CcSEcCtD
Fosfomycin—Infection—Losartan—type 2 diabetes mellitus	0.00115	0.00115	CcSEcCtD
Fosfomycin—Dyspepsia—Metformin—type 2 diabetes mellitus	0.00115	0.00115	CcSEcCtD
Fosfomycin—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00114	0.00114	CcSEcCtD
Fosfomycin—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Fosfomycin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00113	0.00113	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Fosfomycin—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Fosfomycin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Fosfomycin—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Fosfomycin—Constipation—Metformin—type 2 diabetes mellitus	0.00112	0.00112	CcSEcCtD
Fosfomycin—Angioedema—Ramipril—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Fosfomycin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Fosfomycin—Anorexia—Losartan—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Fosfomycin—Vomiting—Glyburide—type 2 diabetes mellitus	0.00111	0.00111	CcSEcCtD
Fosfomycin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.0011	0.0011	CcSEcCtD
Fosfomycin—Rash—Glyburide—type 2 diabetes mellitus	0.0011	0.0011	CcSEcCtD
Fosfomycin—Somnolence—Irbesartan—type 2 diabetes mellitus	0.0011	0.0011	CcSEcCtD
Fosfomycin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00109	0.00109	CcSEcCtD
Fosfomycin—Headache—Glyburide—type 2 diabetes mellitus	0.00109	0.00109	CcSEcCtD
Fosfomycin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00108	0.00108	CcSEcCtD
Fosfomycin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.00107	0.00107	CcSEcCtD
Fosfomycin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00107	0.00107	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00107	0.00107	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00106	0.00106	CcSEcCtD
Fosfomycin—Pain—Irbesartan—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Fosfomycin—Constipation—Irbesartan—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Fosfomycin—Insomnia—Losartan—type 2 diabetes mellitus	0.00105	0.00105	CcSEcCtD
Fosfomycin—Paraesthesia—Losartan—type 2 diabetes mellitus	0.00104	0.00104	CcSEcCtD
Fosfomycin—Myalgia—Ramipril—type 2 diabetes mellitus	0.00104	0.00104	CcSEcCtD
Fosfomycin—Nausea—Glyburide—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Fosfomycin—Abdominal pain—Metformin—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Fosfomycin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Fosfomycin—Somnolence—Losartan—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Fosfomycin—Asthenia—Valsartan—type 2 diabetes mellitus	0.00103	0.00103	CcSEcCtD
Fosfomycin—Dyspepsia—Losartan—type 2 diabetes mellitus	0.00102	0.00102	CcSEcCtD
Fosfomycin—Asthenia—Orlistat—type 2 diabetes mellitus	0.00102	0.00102	CcSEcCtD
Fosfomycin—Pruritus—Valsartan—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Fosfomycin—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Fosfomycin—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00101	0.00101	CcSEcCtD
Fosfomycin—Pruritus—Orlistat—type 2 diabetes mellitus	0.001	0.001	CcSEcCtD
Fosfomycin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000994	0.000994	CcSEcCtD
Fosfomycin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000992	0.000992	CcSEcCtD
Fosfomycin—Pain—Losartan—type 2 diabetes mellitus	0.000992	0.000992	CcSEcCtD
Fosfomycin—Constipation—Losartan—type 2 diabetes mellitus	0.000992	0.000992	CcSEcCtD
Fosfomycin—Rash—Gliclazide—type 2 diabetes mellitus	0.000984	0.000984	CcSEcCtD
Fosfomycin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000983	0.000983	CcSEcCtD
Fosfomycin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000981	0.000981	CcSEcCtD
Fosfomycin—Headache—Gliclazide—type 2 diabetes mellitus	0.000978	0.000978	CcSEcCtD
Fosfomycin—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000974	0.000974	CcSEcCtD
Fosfomycin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000974	0.000974	CcSEcCtD
Fosfomycin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000969	0.000969	CcSEcCtD
Fosfomycin—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000966	0.000966	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000948	0.000948	CcSEcCtD
Fosfomycin—Dizziness—Valsartan—type 2 diabetes mellitus	0.000948	0.000948	CcSEcCtD
Fosfomycin—Anorexia—Ramipril—type 2 diabetes mellitus	0.000948	0.000948	CcSEcCtD
Fosfomycin—Dizziness—Orlistat—type 2 diabetes mellitus	0.000937	0.000937	CcSEcCtD
Fosfomycin—Asthenia—Metformin—type 2 diabetes mellitus	0.000937	0.000937	CcSEcCtD
Fosfomycin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000927	0.000927	CcSEcCtD
Fosfomycin—Pruritus—Metformin—type 2 diabetes mellitus	0.000924	0.000924	CcSEcCtD
Fosfomycin—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000917	0.000917	CcSEcCtD
Fosfomycin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000917	0.000917	CcSEcCtD
Fosfomycin—Vomiting—Valsartan—type 2 diabetes mellitus	0.000912	0.000912	CcSEcCtD
Fosfomycin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000906	0.000906	CcSEcCtD
Fosfomycin—Rash—Valsartan—type 2 diabetes mellitus	0.000904	0.000904	CcSEcCtD
Fosfomycin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000903	0.000903	CcSEcCtD
Fosfomycin—Vomiting—Orlistat—type 2 diabetes mellitus	0.000901	0.000901	CcSEcCtD
Fosfomycin—Insomnia—Ramipril—type 2 diabetes mellitus	0.000899	0.000899	CcSEcCtD
Fosfomycin—Headache—Valsartan—type 2 diabetes mellitus	0.000898	0.000898	CcSEcCtD
Fosfomycin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000893	0.000893	CcSEcCtD
Fosfomycin—Rash—Orlistat—type 2 diabetes mellitus	0.000893	0.000893	CcSEcCtD
Fosfomycin—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000893	0.000893	CcSEcCtD
Fosfomycin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000893	0.000893	CcSEcCtD
Fosfomycin—Headache—Orlistat—type 2 diabetes mellitus	0.000888	0.000888	CcSEcCtD
Fosfomycin—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000884	0.000884	CcSEcCtD
Fosfomycin—Somnolence—Ramipril—type 2 diabetes mellitus	0.000884	0.000884	CcSEcCtD
Fosfomycin—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000875	0.000875	CcSEcCtD
Fosfomycin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000872	0.000872	CcSEcCtD
Fosfomycin—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000864	0.000864	CcSEcCtD
Fosfomycin—Dizziness—Metformin—type 2 diabetes mellitus	0.000863	0.000863	CcSEcCtD
Fosfomycin—Nausea—Valsartan—type 2 diabetes mellitus	0.000852	0.000852	CcSEcCtD
Fosfomycin—Constipation—Ramipril—type 2 diabetes mellitus	0.00085	0.00085	CcSEcCtD
Fosfomycin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000843	0.000843	CcSEcCtD
Fosfomycin—Nausea—Orlistat—type 2 diabetes mellitus	0.000842	0.000842	CcSEcCtD
Fosfomycin—Asthenia—Losartan—type 2 diabetes mellitus	0.000832	0.000832	CcSEcCtD
Fosfomycin—Vomiting—Metformin—type 2 diabetes mellitus	0.00083	0.00083	CcSEcCtD
Fosfomycin—Rash—Metformin—type 2 diabetes mellitus	0.000823	0.000823	CcSEcCtD
Fosfomycin—Dermatitis—Metformin—type 2 diabetes mellitus	0.000823	0.000823	CcSEcCtD
Fosfomycin—Pruritus—Losartan—type 2 diabetes mellitus	0.00082	0.00082	CcSEcCtD
Fosfomycin—Headache—Metformin—type 2 diabetes mellitus	0.000818	0.000818	CcSEcCtD
Fosfomycin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000815	0.000815	CcSEcCtD
Fosfomycin—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000813	0.000813	CcSEcCtD
Fosfomycin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000793	0.000793	CcSEcCtD
Fosfomycin—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000786	0.000786	CcSEcCtD
Fosfomycin—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000786	0.000786	CcSEcCtD
Fosfomycin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000783	0.000783	CcSEcCtD
Fosfomycin—Rash—Irbesartan—type 2 diabetes mellitus	0.000777	0.000777	CcSEcCtD
Fosfomycin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000776	0.000776	CcSEcCtD
Fosfomycin—Nausea—Metformin—type 2 diabetes mellitus	0.000776	0.000776	CcSEcCtD
Fosfomycin—Headache—Irbesartan—type 2 diabetes mellitus	0.000772	0.000772	CcSEcCtD
Fosfomycin—Dizziness—Losartan—type 2 diabetes mellitus	0.000767	0.000767	CcSEcCtD
Fosfomycin—Vomiting—Losartan—type 2 diabetes mellitus	0.000737	0.000737	CcSEcCtD
Fosfomycin—Nausea—Irbesartan—type 2 diabetes mellitus	0.000732	0.000732	CcSEcCtD
Fosfomycin—Rash—Losartan—type 2 diabetes mellitus	0.000731	0.000731	CcSEcCtD
Fosfomycin—Dermatitis—Losartan—type 2 diabetes mellitus	0.00073	0.00073	CcSEcCtD
Fosfomycin—Headache—Losartan—type 2 diabetes mellitus	0.000726	0.000726	CcSEcCtD
Fosfomycin—Asthenia—Ramipril—type 2 diabetes mellitus	0.000713	0.000713	CcSEcCtD
Fosfomycin—Pruritus—Ramipril—type 2 diabetes mellitus	0.000703	0.000703	CcSEcCtD
Fosfomycin—Nausea—Losartan—type 2 diabetes mellitus	0.000689	0.000689	CcSEcCtD
Fosfomycin—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00068	0.00068	CcSEcCtD
Fosfomycin—Dizziness—Ramipril—type 2 diabetes mellitus	0.000658	0.000658	CcSEcCtD
Fosfomycin—Vomiting—Ramipril—type 2 diabetes mellitus	0.000632	0.000632	CcSEcCtD
Fosfomycin—Rash—Ramipril—type 2 diabetes mellitus	0.000627	0.000627	CcSEcCtD
Fosfomycin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000626	0.000626	CcSEcCtD
Fosfomycin—Headache—Ramipril—type 2 diabetes mellitus	0.000623	0.000623	CcSEcCtD
Fosfomycin—Nausea—Ramipril—type 2 diabetes mellitus	0.000591	0.000591	CcSEcCtD
